close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

2.890 UNCHANGED
Delayed Quote Updated: 8:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15
Open 2.890
Bid (Size) 2.320 (100)
Ask (Size) 3.350 (100)
Prev. Close 2.890
Today's Range 2.890 - 2.890
52wk Range 1.510 - 59.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Leveraging Four-Part Ecosystem with MindChain at Its Core
Via Investor Brand Network
TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Announces MindWave NILA Token Listing on Pionex Exchange
Via Investor Brand Network

Performance

52-Week Range 95.2% below 52-week high
2.890
1.5152W Low 59.7052W High
1 Week 26.8% below 1-week high
2.811W Low 3.951W High

Apimeds Pharmaceuticals US, Inc. Common Stock (APUS) traded between $1.51 and $59.70 over the past 52 weeks and last traded at $2.89, 95.2% below its 52-week high. Over the past week it ranged between $2.81 and $3.95.

Past 12 Months
-17.4%
-60.1%
-54.1%
-90.4%
-82.6%
-85.0%
1W -$0.61
1M -$4.36
3M -$3.40
6M -$27.11
YTD -$13.76
1Y -$16.41

APUS was -85.0% over the past year, -90.4% over six months, -82.6% year to date, -17.4% in the last week.

12 Months vs Market
APUS
-85.0%
DIA
+9.7%
SPY
+10.9%
QQQ
+12.1%
IWM
+10.2%

Over the past 12 months APUS returned -85.0% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.9%, QQQ (Nasdaq 100) +12.1% and IWM (Russell 2000) +10.2%.

Volume & Liquidity 0.00× 3-mo avg
Today 15 3-mo avg 3.8M
1W
75.1K
1M
7.0M
3M
3.8M
6M
2.0M
YTD
1.3M
1Y
1.1M

APUS most recently traded 15 shares against a 3-month average daily volume of 3.8M.

More News

Read More
MissionIRNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Three Blockchain Network Agreements Across Three Industries
Via Investor Brand Network
MindWave Innovations Inc. (NYSE American: APUS) Pairs Insured Blockchain with Multi-Vertical Commercial Strategy
Via Investor Brand Network
What's going on in today's session ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
MindWave Innovations Inc. (NYSE American: APUS) Builds the Infrastructure Behind a Growing Blockchain Ecosystem
Via Investor Brand Network
Monday's session: top gainers and losers ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Two-Year Agreement to Build and Operate AssureChain
Via Investor Brand Network
CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Signs Two-Year Agreement to Build and Operate AssureChain
Via CryptoCurrencyWire
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary, MindWave Innovations, Signs 12-Month Agreement to Build FlashChain
Via Investor Brand Network
These stocks are moving in today's pre-market session ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill
Unusual volume stocks are being observed in Friday's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Emerging Growth DRK GLND APUS GCTK Stocks in the News
Via AB Newswire
Topics Artificial Intelligence
News headline image
DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region
Via AB Newswire
Topics Artificial Intelligence
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
Discover the most active stocks in Thursday's session. ↗
Via Chartmill
TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings
Via Investor Brand Network
Topics Retirement
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Apimeds Pharmaceuticals US, Inc. Common Stock publicly traded?
Yes, Apimeds Pharmaceuticals US, Inc. Common Stock is publicly traded.
What exchange does Apimeds Pharmaceuticals US, Inc. Common Stock trade on?
Apimeds Pharmaceuticals US, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock?
The ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock is APUS on the New York Stock Exchange
What is the current price of Apimeds Pharmaceuticals US, Inc. Common Stock?
The current price of Apimeds Pharmaceuticals US, Inc. Common Stock is 2.890
When was Apimeds Pharmaceuticals US, Inc. Common Stock last traded?
The last trade of Apimeds Pharmaceuticals US, Inc. Common Stock was at 10/23/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.